These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 33307186)

  • 21. The many faces of alpha-synuclein mutations.
    Kasten M; Klein C
    Mov Disord; 2013 Jun; 28(6):697-701. PubMed ID: 23674458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exon dosage variations in Brazilian patients with Parkinson's disease: analysis of SNCA, PARKIN, PINK1 and DJ-1 genes.
    Moura KC; Junior MC; de Rosso AL; Nicaretta DH; Pereira JS; José Silva D; Santos-Rebouças CB; Pimentel MM
    Dis Markers; 2012; 32(3):173-8. PubMed ID: 22377733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatic alpha-synuclein mutations in Parkinson's disease: hypothesis and preliminary data.
    Proukakis C; Houlden H; Schapira AH
    Mov Disord; 2013 Jun; 28(6):705-12. PubMed ID: 23674490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low prevalence of known pathogenic mutations in dominant PD genes: A Swedish multicenter study.
    Puschmann A; Jiménez-Ferrer I; Lundblad-Andersson E; Mårtensson E; Hansson O; Odin P; Widner H; Brolin K; Mzezewa R; Kristensen J; Soller M; Rödström EY; Ross OA; Toft M; Breedveld GJ; Bonifati V; Brodin L; Zettergren A; Sydow O; Linder J; Wirdefeldt K; Svenningsson P; Nissbrandt H; Belin AC; Forsgren L; Swanberg M
    Parkinsonism Relat Disord; 2019 Sep; 66():158-165. PubMed ID: 31422003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A53T in a parkinsonian family: a clinical update of the SNCA phenotypes.
    Tambasco N; Nigro P; Romoli M; Prontera P; Simoni S; Calabresi P
    J Neural Transm (Vienna); 2016 Nov; 123(11):1301-1307. PubMed ID: 27250986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients.
    Boros FA; Török R; Vágvölgyi-Sümegi E; Pesei ZG; Klivényi P; Vécsei L
    Neurosci Lett; 2019 Jul; 706():140-145. PubMed ID: 31085292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SNCA but not DNM3 and GAK modifies age at onset of LRRK2-related Parkinson's disease in Chinese population.
    Yang ZH; Li YS; Shi MM; Yang J; Liu YT; Mao CY; Fan Y; Hu XC; Shi CH; Xu YM
    J Neurol; 2019 Jul; 266(7):1796-1800. PubMed ID: 31041581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil.
    Abreu GM; Valença DC; Campos M; da Silva CP; Pereira JS; Araujo Leite MA; Rosso AL; Nicaretta DH; Vasconcellos LF; da Silva DJ; Della Coletta MV; Dos Santos JM; Gonçalves AP; Santos-Rebouças CB; Pimentel MM
    Neurosci Lett; 2016 Dec; 635():67-70. PubMed ID: 27777137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autosomal dominant Parkinson's disease caused by SNCA duplications.
    Konno T; Ross OA; Puschmann A; Dickson DW; Wszolek ZK
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(Suppl 1):S1-6. PubMed ID: 26350119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study.
    Wilson H; Dervenoulas G; Pagano G; Koros C; Yousaf T; Picillo M; Polychronis S; Simitsi A; Giordano B; Chappell Z; Corcoran B; Stamelou M; Gunn RN; Pellecchia MT; Rabiner EA; Barone P; Stefanis L; Politis M
    Lancet Neurol; 2019 Aug; 18(8):748-759. PubMed ID: 31229470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha-synuclein polymorphisms are associated with Parkinson's disease in a Saskatchewan population.
    Rajput A; Vilariño-Güell C; Rajput ML; Ross OA; Soto-Ortolaza AI; Lincoln SJ; Cobb SA; Heckman MG; Farrer MJ; Rajput A
    Mov Disord; 2009 Dec; 24(16):2411-4. PubMed ID: 19890971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variants in the 3'UTR of SNCA do not affect miRNA-433 binding and alpha-synuclein expression.
    Schmitt I; Wüllner U; van Rooyen JP; Khazneh H; Becker J; Volk A; Kubisch C; Becker T; Kostic VS; Klein C; Ramirez A
    Eur J Hum Genet; 2012 Dec; 20(12):1265-9. PubMed ID: 22617348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic analysis of SNCA coding mutation in Chinese Han patients with Parkinson disease.
    Deng S; Deng X; Yuan L; Song Z; Yang Z; Xiong W; Deng H
    Acta Neurol Belg; 2015 Sep; 115(3):267-71. PubMed ID: 25092551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variants in the SNCA gene associate with motor progression while variants in the MAPT gene associate with the severity of Parkinson's disease.
    Wang G; Huang Y; Chen W; Chen S; Wang Y; Xiao Q; Liu J; Fung VS; Halliday G; Chen S
    Parkinsonism Relat Disord; 2016 Mar; 24():89-94. PubMed ID: 26776090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expanding the clinical phenotype of SNCA duplication carriers.
    Nishioka K; Ross OA; Ishii K; Kachergus JM; Ishiwata K; Kitagawa M; Kono S; Obi T; Mizoguchi K; Inoue Y; Imai H; Takanashi M; Mizuno Y; Farrer MJ; Hattori N
    Mov Disord; 2009 Sep; 24(12):1811-9. PubMed ID: 19562770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic assessment of familial and early-onset Parkinson's disease in a Greek population.
    Bozi M; Papadimitriou D; Antonellou R; Moraitou M; Maniati M; Vassilatis DK; Papageorgiou SG; Leonardos A; Tagaris G; Malamis G; Theofilopoulos D; Kamakari S; Stamboulis E; Hadjigeorgiou GM; Athanassiadou A; Michelakakis H; Papadimitriou A; Gasser T; Stefanis L
    Eur J Neurol; 2014 Jul; 21(7):963-8. PubMed ID: 24313877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic variants of SNCA and LRRK2 genes are associated with sporadic PD susceptibility: a replication study in a Taiwanese cohort.
    Wu-Chou YH; Chen YT; Yeh TH; Chang HC; Weng YH; Lai SC; Huang CL; Chen RS; Huang YZ; Chen CC; Hung J; Chuang WL; Lin WY; Chen CH; Lu CS
    Parkinsonism Relat Disord; 2013 Feb; 19(2):251-5. PubMed ID: 23182315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age at onset in LRRK2-associated PD is modified by SNCA variants.
    Botta-Orfila T; Ezquerra M; Pastor P; Fernández-Santiago R; Pont-Sunyer C; Compta Y; Lorenzo-Betancor O; Samaranch L; Martí MJ; Valldeoriola F; Calopa M; Fernández M; Aguilar M; de Fabregas O; Hernández-Vara J; Tolosa E
    J Mol Neurosci; 2012 Sep; 48(1):245-7. PubMed ID: 22669510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 123I-FP-CIT SPECT [(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α-synuclein Parkinson's disease cohort versus Parkinson's disease.
    Koros C; Simitsi A; Prentakis A; Beratis I; Papadimitriou D; Kontaxopoulou D; Fragkiadaki S; Papagiannakis N; Seibyl J; Marek K; Papageorgiou SG; Trapali XG; Stamelou M; Stefanis L
    Mov Disord; 2018 Nov; 33(11):1734-1739. PubMed ID: 30288781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of SNCA variants with α-synuclein of gastric and colonic mucosa in Parkinson's disease.
    Chung SJ; König IR; Lohmann K; Hinrichs F; Kim J; Ryu HS; Lee HJ; Kim K; Lee JH; Jung KW; Kim MJ; Kim MJ; Kim YJ; Yun SC; Hong SM; Myung SJ; Klein C
    Parkinsonism Relat Disord; 2019 Apr; 61():151-155. PubMed ID: 30424941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.